We use cookies to maximize your online experience with us. By closing this window, you consent to our cookie policy. You can change your cookie settings in your browser any time. For more information, please see our Privacy Policy located on the footer of this site.
Cost Efficient, Open-space Office Designs: Ditching Desks — and Privacy

Things you will find upon arriving for work each morning at GlaxoSmithKline in Philadelphia’s Navy Yard: A tranquility room for prayer, a rooftop perch with city views for impromptu meetings, work stations that allow for typing at a keyboard while simultaneously walking two miles an hour on the treadmill, and a fairly good chance that at some point during the day you will bump into the CEO.
What you won’t find anywhere in the 208,000-square-foot space: a desk of your own.
GSK’s office design reflects a new approach to the workplace, one that embraces an open-space philosophy and uses a concept sometimes called “hoteling.” All workers, even top management, are assigned to “neighborhoods” — areas of workers engaged in related tasks — but no one has a permanent desk. Personal belongings go in a small locker.
Many employees work at computer terminals standing. Everyone is encouraged to float — in the cafeteria, on top of the deck beside a green roof filled with indigenous plants, on a sofa in a quiet room or in the lobby. The idea is that chance encounters will spark conversations and collaboration that would not happen when creative minds are moored to a single assigned desk. In GSK parlance, it’s called “smart-working.”
It might also be called smart cost containment. The new design allowed GSK to fit the same number of employees — 1,300 at this facility — into square footage that is a quarter of the size they previously occupied.
Open-space ideals began immigrating to this country from Europe in the 1950s and 1960s and have cropped up periodically since. But with the opening of some recent high-profile headquarters — Google, Facebook, Apple — many are once again embracing the movement. Two other large pharmaceutical firms have come in to study the GSK facility and are considering something similar, say GSK officials. “It was a trend in the 1980s and then it seemed to go away. Now it’s coming back again,” notes Wharton management professor Nancy Rothbard. “I think there are a lot of benefits to it, and then also some costs.”